Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian lariasis
|
|
- Valentine Warner
- 6 years ago
- Views:
Transcription
1 Tropical Medicine and International Health volume 6 no 1 pp 37±41 january 2001 Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian lariasis David O. Freedman 1, D. Adam Plier 1, Adriana B. de Almeida 1, Ana Luna de Oliveira 1, Janaina Miranda 2 and Cynthia Braga 2 1 Division of Geographic Medicine, Department of Medicine, University of Alabama, Birmingham, USA 2 Centro de Pesquisas Aggeu MagalhaÄes, FundacËaÄo Oswaldo Cruz, Recife, Pernambuco, Brazil Summary BACKGROUND Single dose diethylcarbamazine (DEC) as used in control programmes is effectively micro laricidal for periods of up to a year or more but has incomplete ability to kill Wuchereria bancrofti adult parasites. These regimens can be effective in breaking transmission by suppression of circulating micro lariae available to mosquito vectors. Whether prolonged or aggressive therapy with DEC has a signi cant effect on adult worms, which may live up to 12 years or more, and is important in the context of the treatment of individual patients, is still incompletely understood. METHODS In order to investigate the adulticidal effect of aggressive therapy, DEC was given at 6 mg/kg/day for 12-day courses at 0, 6, 12, and 18 months and Og4C3 antigenaemia followed over two years in 38 CAg + Brazilians in a W. bancrofti endemic area. RESULTS At two year follow-up, the median level of antigenaemia was 21% of the pre-treatment value. 92% of individuals had antigen levels < 50% of pretreatment values, but only 26% had completely cleared antigenaemia. The clearance rate at 24 months was only 12% (3/26) in the asymptomatic CAg + patients but 58% (7/12) in those with clinical manifestations of lariasis. The latter individuals cleared signi cantly more antigen (median of 0% pretreatment antigenaemia vs. 26%; P ˆ 0.02) than asymptomatic but infected individuals. CONCLUSION Aggressive repeated therapy with DEC alone is ineffective in consistently eradicating adult W. bancrofti, especially in infected but asymptomatic individuals. Prolonged courses of combination therapy with other anti larial drugs should be investigated for treatment of individual patients with the means to pursue aggressive personal medical care. keywords W. bancrofti, DEC, antigenaemia, control programmes correspondence David O. Freedman, Division of Geographic Medicine, Department of Medicine, University of Alabama at Birmingham, rd Ave S., BBRB #203, Birmingham, AL , USA. Telephone: ; Fax: ; dfreedman@geomed.dom.uab.edu Introduction More than 120 million people in 76 countries are infected with the lymphatic larial parasites Wuchereria bancrofti (90% of cases) and Brugia malayi (10% of cases). Single doses or single short courses of diethylcarbamazine (DEC), ivermectin, or albendazole either alone or in combination are effectively micro laricidal for periods of up to a year or more. These regimens are designed for public health programs where the aim is to break transmission by suppression of circulating micro lariae available to mosquito vectors. However, the effect of any of these drugs in killing adult Wuchereria bancrofti worms, which may live for 12 years or more, is still incompletely understood. With the recent ability to measure serum circulating antigen (CAg), a sensitive indicator of the presence of live adult larial parasites, some direct data on the dosage and time required for DEC to kill adult worms is starting to emerge. In studies of single dose or single course regimens of up to 72 mg/kg total dose, antigenaemia is completely cleared in only 0±18% of infected individuals followed for one to three years (Weil et al. 1988, 1999; Eberhard et al. 1997; ã 2001 Blackwell Science Ltd 37
2 Nicolas et al. 1997; Ismail et al. 1998). In these studies, at follow-up, median pretreatment antigen levels ranged from 23% to 57% with extremely wide variations in antigen clearance among individuals within each patient cohort. As DEC has clear but incomplete adulticidal activity in limited courses, the question of whether prolonged or aggressive therapy with DEC has more signi cant adulticidal activity is important in the context of individual patients. In asymptomatic infected individuals (either from endemic areas or from other countries) with suf cient means for personal medical care, eradication of adult parasites might prevent onset of clinical disease, or attenuate disease in those who already have clinical manifestations of lymphatic in ammation. We wanted to assess, by following circulating antigenaemia over two years, the adulticidal effect of aggressive therapy with DEC given at 6 mg/kg/day for 12-day courses repeated every six months. Materials and methods Human subjects We studied 38 subjects residing in neighbouring communities of metropolitan Recife, Brazil, where W. bancrofti is endemic, from June 1997 to July Subjects were initially classi ed into two groups based on their current infection status (CAg+ vs. CAg±). All subjects, regardless of CAg status or clinical manifestations, were treated with diethylcarbamazine (DEC) 6 mg/kg/day in three divided doses for 12 days and were then treated again at 6, 12, and 18 months using the same dosing regimen. Prior to each treatment course, adherence to the previous course was veri ed by pill counts and detailed one-to-one private interviews, and a daytime serum for CAg was drawn and frozen at )70 C. Patients missing one or more treatment courses were excluded from nal analysis. Subjects were otherwise free of any intercurrent illness. None had received diethylcarbamazine, albendazole, or ivermectin therapy within the previous ve years. out by the manufacturer (Trop-Ag W. bancrofti, TropBio Pty Ltd, Townsville, Australia). Boiling pre-treatment was used and the nal serum dilution was 1:4. Samples were run in duplicate. Serial specimens on individual patients were run in adjacent wells. Results are expressed in manufacturer's arbitrary antigen units using the supplied Onchocerca gibsoni standards (negative cutoff ˆ 32 units). The assay does not cross-react with other larial species or related intestinal nematodes (More & Copeman 1990; Weil et al. 1997). The larial antigen test detects adult worm products in human sera and a positive result indicates the presence of living adult worms. Statistical analysis Data management and analyses were performed with Statview version 4.0 software. The non-parametric Mann± Whitney U-test was used for comparison of ages and antigen clearance between patient groups. Results Patient population As shown in Table 1, at enrolment, 38 subjects were CAg+ with a median age of 30.5 years (range 15±62). 22 were male (median age 30.0 years) and 16 female (median age 30.5 years). 26/38 were asymptomatic (clinical lariasis negative, CF±) with no current or previous history of adenolymphangitis, erysipelas, cellulitis, or limb swelling. 12/38 individuals had clinical lariasis (CF+) including eight males with hydrocele only and four females with lymphoedema. Median age did not differ between CF+ (32 years) and CF± (30.5 years) individuals. Nineteen CAg± control individuals with overt clinical lariasis (with positive anti larial IgG) were treated in the same way and remained CAg± through follow-up, and will not be discussed further. Ethical approval All subjects gave written informed consent according to human experimentation guidelines of the US Department of Health and Human Services. The protocol was approved by the Institutional Review Board of the University of Alabama at Birmingham. Circulating antigen assay Levels of circulating W. bancrofti antigen in sera were determined using the Og4C3 antigen ELISA exactly as set Table 1 Clinical ndings in study subjects Clinical classi cation Number of study subjects Male/ Female Age (range) CAg+ CF± 26 14/ (15±62) CAg+ CF+ (total) 12 8/ (15±54) CAg+ CF+ hydrocele 8 8/ (15±42) CAg+ CF+ lymphoedema 4 0/ (35±54) CAg±CF+ (controls) 19 4/ (24±62) 38 ã 2001 Blackwell Science Ltd
3 Filarial antigen clearance Figure 1 shows individual antigen unit levels for all individual CAg + patients at 0, 12, and 24 months. While every patient had decreasing antigen levels with time as a result of the repeated aggressive treatment, only 5.7% (2/35) completely cleared antigenaemia after one treatment (6-month follow-up; data not shown) and only 26% (10/38) completely cleared after two years. Interestingly, the clearance rate at 24 months was only 12% (3/26) in the asymptomatic CAg+ CF± patients but 58% (7/12) in the CAg+ CF+ individuals. 38% (3/8) of CF + patients with hydrocele only as compared to 100% (4/4) with lymphoedema completely cleared antigenaemia. In order to quantify larial antigen clearance with time, antigen unit levels were examined as a percentage of each CAg+ individual's pre-treatment value (Fig. 2a). As clearance of antigen was highly variable between individuals, median values are used to compare time points. After one course of DEC (6-month follow-up) the median (25±75% interquartile range) level of CAg was 53% (35±73%) of the pre-treatment value. This decreased with further regular courses of DEC to 32% (19±55%) at 12 months and 21% (4±36%) at 24 months. At 24 months, 92% (35/38) of individuals had antigen levels that were less than 50% of pre-treatment values and the other three individuals had at least a moderate response (78, 71, 71% of pre-treatment). In marked contrast, after one course of DEC, only 43% (15/35) had antigen levels < 50% of pre-treatment values. Figure 1 Filarial antigen levels expressed in Og4r C3 antigen units in individual CAg+ patients after two courses of DEC 6 mg/ kg/day for 12 days (12-month follow-up) and after six-monthly therapy for two years. Open circles indicate asymptomatic (CF±) individuals and closed circles individuals with clinical lariasis (CF+). Negative cutoff value for the assay is 32 units. Figure 2(a) kinetics of larial antigen clearance over time in all 38 CAg+ individuals. Antigen levels are expressed as a percentage of each individuals pretreatment antigen value. (b) comparison of antigen clearances at each time point between asymptomatic (CF±) and clinical lariasis (CF+) patients. For each time point the boxes and horizontal line delimit the 25th and 75th percentile as well as the median pretreatment value. The whiskers denote 10th and 90th percentiles and outlying points are each separately shown. ã 2001 Blackwell Science Ltd 39
4 Pre-treatment antigen unit values were not signi cantly different between CAg+ CF+ (geometric mean ˆ 820 units) and asymptomatic CAg+ CF± (geometric mean ˆ 874 units) individuals. However, when median antigen clearances were compared between the CF+ and CF± groups (Fig. 2b), we found that the CF+ group cleared signi cantly more antigen at 6 months (CF+ ˆ 33% pretreatment vs. CF± ˆ 58%; P ˆ 0.02), 12 months (CF+ ˆ 17% pre-treatment vs. CF± ˆ 38%; P ˆ 0.008), and 24 months (CF+ ˆ 0% pre-treatment vs. CF± ˆ 26%; P ˆ 0.02). Discussion The degree of activity of the three major anti larial drugs (DEC, ivermectin, albendazole) against adult Wuchereria bancrofti worms is still incompletely understood. With the recent ability to measure serum CAg, a sensitive indicator of the presence of live adult larial parasites, some direct data on the dosage and time required for these drugs to kill adult worms is emerging. Animal studies have shown that CAg levels correlate with the number of adult worms in the host. Decreased CAg after treatment in humans should thus re ect proportionate death of adult worms. Most published studies have followed CAg levels over time after single dose or single course (up to 72 mg/kg) therapies (Weil et al. 1988; Eberhard et al. 1997; Nicolas et al. 1997; Ismail et al. 1998; Weil et al. 1999) used in the context of control programs where the primary goal has been to reduce micro laraemia and interrupt transmission to mosquito vectors. In Tahiti, after a 6-mg/kg single dose of DEC, the median level of CAg was 29.6% of pretreatment values at two years and 9.5% of treated individuals completely cleared antigenaemia (Nicolas et al. 1997). In Egypt, DEC 6 mg/kg/day for 12 consecutive days resulted in median levels of CAg of 57% pre-treatment values and a complete clearance rate of 18% at 1 year (Weil et al. 1999). However, in that study, an untreated group had a complete clearance rate of 20%. In Haiti, DEC 6 mg/kg once per week for 12 weeks resulted in a median level of CAg 25% of pre-treatment values at three years with no patient completely clearing antigenaemia (Eberhard et al. 1997). In Sri Lanka, DEC 6 mg/kg in a single dose combined with a single dose of 600 mg of albendazole resulted in median pre-treatment levels of 23% at 15 months with no patient completely clearing antigenaemia (Ismail et al. 1998). This was signi cantly better than in a comparison group treated in the same study with albendazole alone and there was no DEC-only arm. Thus, single course therapy appears to result in no better than a residual antigenaemia of 23% of pretreatment levels. Only two studies have examined CAg levels after slightly more aggressive treatment. Ismail et al. (1996) treated 12 asymptomatic Sri Lankan individuals with 10 mg/kg doses of DEC repeated every two weeks for 11 doses (total dose 110 mg/kg). After two years, 7/12 had completely cleared antigenaemia and the median level of CAg was 10.0% of pre-treatment values. McCarthy et al. (1995) treated 18 Cook Islanders with DEC 8 mg/kg/day for 7 consecutive days repeated ve more times over 6 months (total dose 336 mg/kg) resulting in complete antigen clearance in 80% at 18 months. However, in that study, the subjects were noted to be extremely lightly infected with median micro- laria counts of just 32 mf/ml and with mean CAg levels signi cantly lower than those found in other parts of the South Paci c. We examined a cohort with substantial CAg levels treated repeatedly (every six months) over a two year period (total DEC dose 288 mg/kg). At 24 months, the median level of CAg was 21% of pre-treatment values and the complete clearance rate of 26% is comparable with that found in the studies discussed above. Ultrasonographic visualization of scrotal lymphatics after treatment has suggested inter-individual variability in susceptibility of adult W. bancrofti to DEC (Noroes et al. 1997). The present study extends these preliminary ndings on localized adult worms by examining the response to DEC of the total body burden of adult W. bancrofti as manifest by CAg levels. An unexpected nding, however, was the striking and signi cantly increased adulticidal effect of DEC in those CAg+ individuals who also had overt clinical manifestations of lariasis (Figs 1 and 2b). This was manifest by an overall clearance rate of 58% vs. 12% in CF + compared to CF± subjects and a median residual antigenaemia of 0% vs. 26% in the former compared to the latter group. Lymphoedema patients are generally older and thought to be at a more advanced stage of disease than those with hydrocele only. 38% (3/8) of CF+ patients with hydrocele only completely cleared antigenaemia, compared to 100% (4/4) with lymphoedema. Previous work has suggested that these CAg+ CF+ individuals possess clinical and immunological characteristics that distinguish them from those that are CAg+ and asymptomatic, and that they should be treated as a separate group (de Almeida et al. 1996; Freedman 1998). One may hypothesize that the same host factors that lead to increased in ammatory manifestations to the larial infection in these individuals may potentiate the actions of DEC in clearing adult W. bancrofti worms. Though the numbers are small, the nding that all individuals in the group with the most advanced in ammatory disease, the lymphoedema patients, cleared antigenaemia, compared to 40 ã 2001 Blackwell Science Ltd
5 38% of hydrocele patients and 12% of asymptomatic infected individuals, supports this hypothesis. These overall results indicate: considerable inter-individual heterogeneity in response to DEC indicating a possible contribution of host factors; some bene t of prolonged therapy on residual antigenaemia in CF+ patients but only a very modest effect in CF± individuals; and an inability to eradicate adult larial worms in most individuals even with prolonged DEC therapy. Combination therapy with more than one anti larial drug is now recommended for short course regimens in control programs. Prolonged courses of DEC are currently recommended as the therapy of choice for individual patients with clinical manifestations of bancroftian lariasis. Our results indicate that this is wholly inadequate for eradicating all viable adult parasites in the asymptomatic individuals that comprise the bulk of most infected populations. Prolonged courses of combination therapy should be investigated for treatment of individual patients with the nancial means for personal medical care, where the goal should be to eradicate adult parasites. Acknowledgements We thank Drs Alexandre Bezerra de Carvalho and Andre Furtado for the continuing support of CPqAM in conducting these studies, and are grateful to Luiz Carlos Alves and LaÃnia Ferreira da Silva for technical and data assistance in Brazil. We thank the staff of the Secretary of Health, Municipality of Olinda for use of clinical facilities and for logistical support. Financial support was provided by PHS grant NIAID RO1 AI References Eberhard ML, Hightower AW, Addiss DG & Lammie PJ (1997) Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. American Journal of Tropical Medicine and Hygiene 57, 483±486. Freedman DO (1998) Immune dynamics in the pathogenesis of human lymphatic lariasis. Parasitology Today 14, 229±234. Ismail MM, Jayakody RL, Weil GJ et al. (1998) Ef cacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian lariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 94±97. Ismail MM, Weil GJ, Jayasinghe KSA et al. (1996) Prolonged clearance of micro laremia in patients with bancroftian lariasis after multiple high doses of ivermectin or diethylcarbamazine. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 684±688. McCarthy JS, Guinea A, Weil GJ & Ottesen EA (1995) Clearance of circulating larial antigen as a measure of the macro laricidal activity of diethylcarbamazine in Wuchereria bancrofti infection. Journal of Infectious Diseases 172, 521±526. More SJ & Copeman DB (1990) A highly speci c and sensitive monoclonal antibody-based ELISA for the detection of circulating antigen in bancroftian lariasis. Tropical Medicine and Parasitology 41, 403±406. Nicolas L, Plichart C, Nguyen LN & Moulia Pelat JP (1997) Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia. Journal of Infectious Diseases 175, 489±492. NoroÄ es J, Dreyer G, Santos A, Mendes VG, Medeiros Z & Addiss D (1997) Assessment of the ef cacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 78±81. Weil GJ, Lammie PJ & Weiss N (1997) The ICT Filariasis test: a rapid-format antigen test for diagnosis of bancroftian lariasis. Parasitology Today 13, 401±404. Weil GJ, Ramzy RM, El Setouhy M, Kandil AM, Ahmed ES & Faris R (1999) A longitudinal study of Bancroftian lariasis in the Nile Delta of Egypt: baseline data and one-year follow-up. American Journal of Tropical Medicine and Hygiene 61, 53±58. Weil GJ, Sethumadhavan KV, Santhanam S, Jain DC & Ghosh TK (1988) Persistence of parasite antigenaemia following diethylcarbamazine therapy of bancroftian lariasis. American Journal of Tropical Medicine and Hygiene 38, 589±595. ã 2001 Blackwell Science Ltd 41
The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort
Tropical Medicine and International Health volume 6 no 3 pp 190±195 march 2001 The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort
More informationEvaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti in South India
TMIH559 Tropical Medicine and International Health volume 5 no 5 pp 359 363 may 2000 Evaluation of the ICT whole blood antigen card test to detect infection due to nocturnally periodic Wuchereria bancrofti
More informationAbraham Rocha 1 / +, Cynthia Braga 1, Marcela Belém 1, Arturo Carrera 1, Ana Aguiar-Santos 1, Paula Oliveira 1, Maria José Texeira 1, André Furtado 2
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 104(4): 621-625, July 2009 621 Comparison of tests for the detection of circulating filarial antigen (Og4C3-ELISA and AD12-ICT) and ultrasound in diagnosis of
More informationSensitivity and Specificity of ELISA in Detection of Microfilariae
ORIGINAL ARTICLE Sensitivity and Specificity of in Detection of Microfilariae Lakshmi Jyothi 1, MVR Reddy 2 1. Associate Professor of Microbiology, Medicity Institute of Medical Sciences, Hyderabad. 2.
More informationINTRODUCTION MATERIALS AND METHODS
Am. J. Trop. Med. Hyg., 70(2), 2004, pp. 191 196 Copyright 2004 by The American Society of Tropical Medicine and Hygiene A RANDOMIZED CLINICAL TRIAL COMPARING SINGLE- AND MULTI-DOSE COMBINATION THERAPY
More informationEpidemiology and immunopathology of bancroftian filariasis
Microbes and Infection, 1, 1999, 1015 1022 1999 Éditions scientifiques et médicales Elsevier SAS. All rights reserved Review Epidemiology and immunopathology of bancroftian filariasis Adriana B. de Almeida*,
More informationMeasuring impact on filarial infection status in a community study: Role of coverage of mass drug administration (MDA)
Tropical Biomedicine 31(2): 225 229 (2014) Measuring impact on filarial infection status in a community study: Role of coverage of mass drug administration (MDA) Anil Kumar 1* and Pawan Sachan 2 National
More informationDownloaded from:
O Hara, GA; Elliott, AM (2016) HIV and Helminths - Not All Worms Created Equal? Trends in parasitology. ISSN 1471-4922 DOI: https://doi.org/10.1016/j.pt.2016 Downloaded from: http://researchonline.lshtm.ac.uk/3327115/
More informationPARASITOLOGY CASE HISTORY #13 (BLOOD PARASITES) (Lynne S. Garcia)
PARASITOLOGY CASE HISTORY #13 (BLOOD PARASITES) (Lynne S. Garcia) An epidemiologic survey was undertaken in a small town in Myanmar (Burma) endemic for lymphatic filariasis. Blood specimens were collected
More informationMASS TREATMENT FOR LYMPHATIC FILARIASIS MASS TREATMENT TO ELIMINATE FILARIASIS IN PAPUA NEW GUINEA
MASS TREATMENT FOR LYMPHATIC FILARIASIS MASS TREATMENT TO ELIMINATE FILARIASIS IN PAPUA NEW GUINEA MOSES J. BOCKARIE, PH.D., DANIEL J. TISCH, M.P.H., WILL KASTENS, B.SC., NEAL D.E. ALEXANDER, PH.D., ZACHARY
More information44th Myanmar Health Research Congress
44th Myanmar Health Research Congress Early Detection of Lymphatic Disturbance in Adolescent Infected with Lymphatic Filariasis Jan Douglass 1, Susan Gordon 1, Patricia Graves 1, Ben Dickson 1, Dr Ni Ni
More informationMulticentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis
Tropical Medicine and International Health volume 8 no 10 pp 895 900 october 2003 Multicentre laboratory evaluation of Brugia Rapid dipstick test for detection of brugian filariasis N. Rahmah 1, R. K.
More informationIMMUNO-EPIDEMIOLOGY OF BANCROFTIAN FILARIASIS : A 14-YEAR FOLLOW-UP STUDY IN ODISHA, INDIA
IMMUNO-EPIDEMIOLOGY OF BANCROFTIAN FILARIASIS : A 14-YEAR FOLLOW-UP STUDY IN ODISHA, INDIA NN Mandal, KG Achary, SK Kar and MS Bal Division of Immunology, Regional Medical Research Centre, Indian Council
More informationLymphatic filariasis in children: Clinical features, infection burdens and future prospects for elimination
Lymphatic filariasis in children: Clinical features, infection burdens and future prospects for elimination 1559 RANGANATHA KRISHNA SHENOY 1 and MOSES J. BOCKARIE 2 * 1 Filariasis Chemotherapy Unit, TD
More informationPurushothaman Jambulingam 1, Swaminathan Subramanian 1*, S. J. de Vlas 2, Chellasamy Vinubala 1 and W. A. Stolk 2
Jambulingam et al. Parasites & Vectors (2016) 9:501 DOI 10.1186/s13071-016-1768-y RESEARCH Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug
More informationSEA-CD-275. Frequently asked questions
SEA-CD-275 Frequently asked questions on LYMPHATIC FILARIASIS (ELEPHANTIASIS) World Health Organization 2013 All rights reserved. Requests for publications, or for permission to reproduce or translate
More informationBancroftian filariasis in an endemic area of Brazil: differences between genders during puberty
ARTIGO/ARTICLE Revista da Sociedade Brasileira de Medicina Tropical 38(3):4-8, mai-jun, 005 Bancroftian filariasis in an endemic area of Brazil: differences between genders during puberty Filariose bancroftiana
More informationDepartments of Pathology and *Parasitology, Faculty of Medicine, University of Malaya
Malaysian J Pathol 2004; 26(2) : 119 123 MICROFILARIA IN HYDROCELE FLUID CYTOLOGY CASE REPORT Microfilaria in hydrocele fluid cytology Patricia Ann CHANDRAN MD, Gita JAYARAM MIAC, FRCPath, *Rohela MAHMUD
More informationPOSTGRADUATE INSTITUTE OF MEDICINE UNIVERSITY OF COLOMBO MD (MEDICAL PARASITOLOGY) EXAMINATION JANUARY, 2001 PAPER 1
JANUARY, 2001 Date: 15 th January 2001 Time: 2.00 p.m. -500 p.m. PAPER 1 Answer all five (5) questions Answer each question in a separate book 1. Discuss the underlying principles relating to the use of
More informationA simple and quick method for enhanced detection of specific IgE in serum from lymphatic filariasis patients
Acta Tropica 80 (2001) 51 57 www.parasitology-online.com A simple and quick method for enhanced detection of specific IgE in serum from lymphatic filariasis patients Walter G. Jaoko a, Mette Lund b, Edwin
More informationIN THIS ISSUE: LYMPHATIC FILARIASIS: ELIMINATING ONE OF HUMANITY S MOST DEVASTATING DISEASES
ACTION AGAINST WORMS JULY 2010 ISSUE 14 Lymphatic filariasis patient, Debaraj Behera, in Dhalapathar, Orissa, India, 2009. IN THIS ISSUE: Lymphatic filariasis: eliminating one of humanity s most devastating
More informationA practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands
Harrington et al. Parasites & Vectors 2013, 6:218 RESEARCH Open Access A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands Humpress Harrington 1, James
More informationShort report: Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2013 Short report: Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen Cedric
More informationLymphatic Filariasis
REFERENCES CONTENT ALERTS Characterization of Antibody Responses to Wolbachia Surface Protein in Humans with Lymphatic Filariasis George A. Punkosdy, David G. Addiss and Patrick J. Lammie Infect. Immun.
More informationWuchereria Morphology 10 cm 250 : m
Wucheria bancrofti Brugia malayi Lymphatic filariasis Lymphatic Filariasis 119 million infected Elephantiasis Manifestation of lymphatic filariasis Morphology I Adult: White and thread-like. Two rings
More informationModel development, quantification and application
4 Model development, quantification and application 4.1 The LYMFASIM simulation program for modelling lymphatic filariasis and its control A.P. Plaisier, S. Subramanian, P.K. Das, W. Souza, T. Lapa, A.F.
More informationChanges in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis
The Journal of Infectious Diseases MAJOR ARTICLE Changes in Cytokine, Filarial Antigen, and DNA Levels Associated With Adverse Events Following Treatment of Lymphatic Filariasis Britt J. Andersen, 1 Jessica
More informationEliminating Lymphatic Filariasis. Success in science, intervention and beyond..
Eliminating Lymphatic Filariasis Success in science, intervention and beyond.. Eric A. Ottesen, M.D. 30 January 2007 LF Disease LF Disease Adult parasites (W. bancrofti) in scrotal lymphatic Dreyer & Noroes
More informationPolicy and technical topics: Selected neglected tropical diseases targeted for elimination: kala-azar, leprosy, yaws, filariasis and schistosomiasis
REGIONAL COMMITTEE Provisional Agenda item 8.3 Sixty-eighth Session SEA/RC68/12 Dili, Timor-Leste 7 11 September 2015 21 July 2015 Policy and technical topics: Selected neglected tropical diseases targeted
More informationImpact of a Community-Based Lymphedema Management Program on Episodes of Adenolymphangitis (ADLA) and Lymphedema Progression - Odisha State, India
Impact of a Community-Based Lymphedema Management Program on Episodes of Adenolymphangitis (ADLA) and Lymphedema Progression - Odisha State, India Katherine E. Mues, Emory University Michael Deming, Emory
More informationHelminths in tropical regions
Helminths in tropical regions Schistosoma spp. Blood flukes Schistosomiasis is one of the most widespread parasitic infections in humans Humans are the principal hosts for: Schistosoma mansoni, Schistosoma
More informationINTRODUCTION. Tropical Biomedicine 23(2): (2006)
Tropical Biomedicine 23(2): 156 162 (2006) Knowledge and perceptions about lymphatic filariasis: a study during the programme to eliminate lymphatic filariasis in an urban community of Orissa, India Rath,
More informationBANCROFTIAN FILARIASIS IN KWALE DISTRICT, KENYA. S.M. NJENGA, M. MUITA, G. KIRIGI, J. MBUGUA, Y. MITSUI, Y. FUJIMAKI and Y.
May 2000 EAST AFRICAN MEDICAL JOURNAL 245 East African Medical Journal Vol. 77 No. 5 May 2000 BANCROFTIAN FILARIASIS IN KWALE DISTRICT, KENYA S.M. Njenga, MSc, M. Muita, MPH, G. Kirigi, Dip. (Clin. Med.)
More informationLymphatic filariasis: new insights and prospects for control Thomas B. Nutman
Lymphatic filariasis: new insights and prospects for control Thomas B Nutman Although lymphatic filariasis remains among the major causes of disability among the tropical infectious diseases, dramatic
More informationElimination of lymphatic filariasis as a public health problem from the Cook Islands
Ave et al. Tropical Medicine and Health (2018) 46:12 https://doi.org/10.1186/s41182-018-0094-9 Tropical Medicine and Health RESEARCH Open Access Elimination of lymphatic filariasis as a public health problem
More informationDIAGNOSTIC SLIDE SESSION CASE 10
DIAGNOSTIC SLIDE SESSION CASE 10 B.K. Kleinschmidt-DeMasters, MD Disclosures: I am not a trainee Caterina made me do this CASE 2016-10: : The patient is a 5-year-old girl with Down syndrome, obstructive
More informationMonitoring and epidemiological assessment of the programme to eliminate lymphatic filariasis at implementation unit level WHO/CDS/CPE/CEE/2005.
AT LIMINATE MPLEMENTATION LEVEL UNIT OF THE PROGRAMME LYMPHATIC FILARIASIS OF THE TO ASSESSMENT TO ELIMINATE AT IMPLEMENTATION ROGRAMME EPIDEMIOLOGICAL AND MONITORING MONITORING AND EPIDEMIOLOGICAL ASSESSMENT
More informationClinical and Pathological Aspects of Filarial Lymphedema and Its Management
MINI-REVIEW Korean J Parasitol. Vol. 46, No. 3: 119-125, September 2008 DOI: 10.3347/kjp.2008.46.3.119 Clinical and Pathological Aspects of Filarial Lymphedema and Its Management R. K. Shenoy Filariasis
More informationRapid Wuchereria-specific Wb123-based IgG4 immunoassays as tools for. surveillance following mass drug administration programs in lymphatic
CVI Accepts, published online ahead of print on 5 June 2013 Clin. Vaccine Immunol. doi:10.1128/cvi.00252-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Rapid Wuchereria-specific
More informationLYMPHATIC FILARIASIS STRENGTHENING THE ASSESSMENT OF LYMPHATIC FILARIASIS TRANSMISSION AND DOCUMENTING THE ACHIEVEMENT OF ELIMINATION
STRENGTHENING THE ASSESSMENT OF LYMPHATIC FILARIASIS TRANSMISSION AND DOCUMENTING THE ACHIEVEMENT OF ELIMINATION MEETING OF THE NEGLECTED TROPICAL DISEASES STRATEGIC AND TECHNICAL ADVISORY GROUP S MONITORING
More informationI. Wuchereria bancrofti
Parasites that affect the Musculoskeletal system (continued) Filarial Worms - Nematodes. - Tissue parasites. - Require an intermediate host, which is usually an insect. - Do not lay eggs like other worms,
More informationFilarial Chyluria as a Rare Cause of Urinary Retention
CASE REPORT Filarial Chyluria as a Rare Cause of Urinary Retention Hideharu Hagiya 1, Tomohiro Terasaka 1, Kosuke Kimura 1, Asuka Satou 1, Kikuko Asano 1, Koichi Waseda 1, Yoshihisa Hanayama 1, Takahide
More informationMicrofilaria persistent foci during post MDA and the risk assessment of resurgence in India
Mehta et al. Tropical Medicine and Health (2018) 46:25 https://doi.org/10.1186/s41182-018-0107-8 Tropical Medicine and Health RESEARCH Microfilaria persistent foci during post MDA and the risk assessment
More informationDiethylcarbamazine and Non-Diethylcarbamazine Related Bancroftian Granuloma: An Immunohistochemical Study of Eosinophil Toxic Proteins
International journal of Biomedical science ORIGINAL ARTICLE Diethylcarbamazine and Non-Diethylcarbamazine Related Bancroftian Granuloma: An Immunohistochemical Study of Eosinophil Toxic Proteins Jose
More informationHistopathologic Improvement with Lymphedema Management, Léogâne, Haiti
Histopathologic Improvement with Lymphedema Management, Léogâne, Haiti Susan F. Wilson,* Jeannette Guarner,* Alix L. Valme, Jacky Louis-Charles, Tara L. Jones,* and David G. Addiss* In countries where
More informationkeywords eradication, Madagascar, mass vaccination campaigns, poliomyelitis, seroprevalence
Tropical Medicine and International Health volume 6 no 12 pp 1032±1039 december 2001 Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children
More informationRegional Medical Research Centre (ICMR), Field Practice Unit, Car Nicobar Andaman & Nicobar Islands & *
Indian J Med Res 141, March 2015, pp 330-339 Impact on prevalence of intestinal helminth infection in school children administered with seven annual rounds of diethyl carbamazine (DEC) with albendazole
More informationA survey on foot care practices among filarial lymphoedema patients in Orissa, India
Tropical Biomedicine 24(2): 7 14 (2007) A survey on foot care practices among filarial lymphoedema patients in Orissa, India Bontha V. Babu, Abhay N. Nayak and Anna S. Kerketta Division of Epidemiology,
More informationFilaria Journal. Open Access. Abstract
Filaria Journal BioMed Central Review Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling Wilma A Stolk*, Sake J de Vlas and J Dik
More informationSubramanian Swaminathan
Modelling Lymphatic Filariasis Transmission and Control Subramanian Swaminathan This thesis was realized with support from a WHO/TDR Research training grant, and with financial support from the Stichting
More informationCHAPTER 1 INTRODUCTION
1 CHAPTER 1 INTRODUCTION 1.1 BACKGROUND Lymphatic filariasis is a mosquito- borne parasitic disease caused by thread like, filaroid nematode worms that include Wucheraria bancrofti, Brugia malayi, and
More informationLymphatic Filariasis: A Method to Identify Subclinical Lower Limb Change in PNG Adolescents
Lymphatic Filariasis: A Method to Identify Subclinical Lower Limb Change in PNG Adolescents Susan Gordon 1 *, Wayne Melrose 1, Jeffrey Warner 2, Petra Buttner 1, Leigh Ward 3 1 School of Public Health,
More informationA critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of lymphatic filariasis
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2007 A critical appraisal of molecular xenomonitoring as a tool for assessing progress toward elimination of lymphatic
More informationHIGH PREVALENCE OF BRUGIA TIMORI INFECTION IN THE HIGHLAND OF ALOR ISLAND, INDONESIA
Am. J. Trop. Med. Hyg., 66(5), 2002, pp. 560 565 Copyright 2002 by The American Society of Tropical Medicine and Hygiene HIGH PREVALENCE OF BRUGIA TIMORI INFECTION IN THE HIGHLAND OF ALOR ISLAND, INDONESIA
More informationRegulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India
Parasite Immunology, 2001: 23: 389±399 Regulation of the immune response in lymphatic filariasis: perspectives on acute and chronic infection with Wuchereria bancrofti in South India THOMAS B.NUTMAN 1
More informationActa Tropica 120S (2011) S55 S61. Contents lists available at ScienceDirect. Acta Tropica. journa l h o me pa g e:
Acta Tropica 120S (2011) S55 S61 Contents lists available at ScienceDirect Acta Tropica journa l h o me pa g e: www.elsevier.com/locate/actatropica Efficacy of home-based lymphoedema management in reducing
More informationDepartment of Parasitology, Faculty of Public Health, Mahidol University, Bangkok; 2
RELATIONSHIP BETWEEN MALE HYDROCELE AND INFECTION PREVALENCES IN CLUSTERED COMMUNITIES WITH UNCERTAIN TRANSMISSION OF WUCHERERIA BANCROFTI ON THE THAILAND-MYANMAR BORDER Adisak Bhumiratana 1, Boontuan
More informationINTRODUCTION MATERIALS AND METHODS
Am. J. Trop. Med. Hyg., 95(6), 2016, pp. 1417 1423 doi:10.4269/ajtmh.16-0547 Copyright 2016 by The American Society of Tropical Medicine and Hygiene Positivity of Antigen Tests Used for Diagnosis of Lymphatic
More informationAn Operational Research on Annual Mass Drug Administration (MDA) For Elimination of Lymphatic Filariasis in Medak District, Telangana
Original Research Article An Operational Research on Annual Mass Drug Administration (MDA) For Elimination of Lymphatic Filariasis in Medak District, Telangana P. Samuel Rajkumar 1*, Tukaram Kishanrao
More informationCHARACTERIZATION OF IMMUNE RESPONSES TO WOLBACHIA IN INDIVIDUALS WITH LYMPHATIC FILARIASIS GEORGE ALBERT PUNKOSDY
CHARACTERIZATION OF IMMUNE RESPONSES TO WOLBACHIA IN INDIVIDUALS WITH LYMPHATIC FILARIASIS by GEORGE ALBERT PUNKOSDY (Under the Direction of Patrick J. Lammie) ABSTRACT Lymphatic filariasis is a parasitic
More informationA survey of treatment practices and burden of lymphoedema in Togo
Transactions of the Royal Society of Tropical Medicine and Hygiene (2007) 101, 391 397 available at www.sciencedirect.com journal homepage: www.elsevierhealth.com/journals/trst A survey of treatment practices
More informationTransactions of the Royal Society of Tropical Medicine and Hygiene
Transactions of the Royal Society of Tropical Medicine and Hygiene 105 (2011) 109 114 Contents lists available at ScienceDirect Transactions of the Royal Society of Tropical Medicine and Hygiene journal
More informationEpidemiological Study of Bancroftian Filariasis in Recife, Northeastern Brazil
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 91(4): 449-455, Jul./Aug. 1996 Epidemiological Study of Bancroftian Filariasis in Recife, Northeastern Brazil Amélia Maciel, Abraham Rocha, Keyla Belizia F Marzochi*,
More informationThe impact of density-dependent processes on the eradicability of parasitic diseases
The impact of density-dependent processes on the eradicability of parasitic diseases Hans Peter Duerr Martin Eichner Klaus Dietz Department of Medical Biometry University of Tübingen Oberwolfach 2004 1/12
More informationThe Filarial Dance Sign in Scrotal Filarial Infection
The Filarial Dance Sign in Scrotal Filarial Infection Poster No.: C-0232 Congress: ECR 2015 Type: Authors: Keywords: DOI: Educational Exhibit P. P. Suthar 1, N. Patel 2 ; 1 Vadodara, Gu/IN, 2 Vadodara,
More informationEffects of prednisolone on murine strongyloidiasis
Parasitology (1981), 83, 401-409 With 2 figures in the text Effects of prednisolone on murine strongyloidiasis D. I. GROVE and H. J. S. DAWKINS Department of Medicine, University of Western Australia and
More informationCoverage and compliance of mass drug administration for elimination of lymphatic filariasis in Khammam district
International Journal of Community Medicine and Public Health Alwala RR et al. Int J Community Med Public Health. 2018 Dec;5(12):5121-5125 http://www.ijcmph.com pissn 2394-6032 eissn 2394-6040 Original
More informationThe Regional Strategic Plan for Elimination of Lymphatic Filariasis
Lymphatic filariasis is the second leading cause of disability worldwide. The WHO South-East Asia Region accounts for about 65% of the global population at risk. Strategic plans for 2007 2010 for lymphatic
More informationIbuprofen versus other non-steroidal anti-in ammatory drugs: use in general practice and patient perception
Aliment Pharmacol Ther 2000; 14: 187±191. Ibuprofen versus other non-steroidal anti-in ammatory drugs: use in general practice and patient perception C. J. HAWKEY 1,D.J.E.CULLEN 1,9,G.PEARSON 1,S.HOLMES
More informationDoungrat Riyong, Wej Choochote, Nimit Morakote, Atchariya Jitpakdi, Benjawan Pitasawat, Prasert Keha and Pongsri Tippawangkosol
EVALUATION OF CRUDE ANTIGEN OF DIROFILARIA IMMITIS THIRD-STAGE LARVA FOR DETECTION OF ANTIBODY AGAINST WUCHERERIA BANCROFTI INFECTION BY INDIRECT ELISA Doungrat Riyong, Wej Choochote, Nimit Morakote, Atchariya
More informationORIGINAL ARTICLE. Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration
ORIGINAL ARTICLE http://dx.doi.org/10.1590/s1678-9946201759023 Knowledge, attitudes and perceptions regarding lymphatic filariasis: study on systematic noncompliance with mass drug administration Silvia
More informationParasitic Protozoa, Helminths, and Arthropod Vectors
PowerPoint Lecture Slides for MICROBIOLOGY ROBERT W. BAUMAN Chapter 23 Parasitic Protozoa, Helminths, and Arthropod Vectors Helminthic Parasites of Humans Helminths are macroscopic, multicellular, eukaryotic
More informationAcute adenolymphangitis due to bancroftian filariasis in Rufiji district, south east Tanzania
ecommons@aku Pathology, East Africa Medical College, East Africa January 2000 Acute adenolymphangitis due to bancroftian filariasis in Rufiji district, south east Tanzania D.B. Gasarasi Muhimbili University
More informationInform'ACTION n 25 DECEMBER 2006
Provisional findings of dengue epidemiological surveillance in French Polynesia 26 Introduction Dengue is present in endemo-epidemic transmission mode throughout the year in French Polynesia (FP), with
More informationModule 2. NTD Strategies
Overview LF and Trachoma MMDP Spectrum of morbidity associated with LF and its impact Cause and management of lymphoedema caused by LF Cause and management of hydrocele caused by LF How LF morbidity management
More informationImpact of Mass Drug Administration on Elimination of Lymphatic Filariasis in Surat city, India
J. Commun. Dis. 44(4) 2012 : 251-259 Impact of Mass Drug Administration on Elimination of Lymphatic Filariasis in Surat city, India Vaishnav KG*, Desai HS*, Srivastava PK**, Joshi PT***, Kurian G***, Thakor
More informationFilarial hydrocele: a neglected condition of a neglected tropical disease
Review Filarial hydrocele: a neglected condition of a neglected tropical disease Kenneth Bentum Otabil 1,2, Seth Boateng Tenkorang 2 ¹ Department of community Medicine and Health, Anglican University College
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/20942 holds various files of this Leiden University dissertation. Author: Wammes, Linda Judith Title: Immune regulation during parasitic infections : from
More informationThis file is part of the following reference:
This file is part of the following reference: Reeve, David Mark (2010) Comparative accuracy and 'field friendly' effectiveness of diagnostic tools for lymphatic filariasis and neurocyticercosis in Papua
More informationINTRODUCTION. Lymphatic filariasis (LF), a deforming and debilitating disease transmitted by
INTRODUCTION Lymphatic filariasis (LF), a deforming and debilitating disease transmitted by '. mosquitoes, causes elephantiasis and male genital damage and is a major social and economic scourge in the
More informationLymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration
Simonsen et al. Parasites & Vectors 2014, 7:507 RESEARCH Open Access Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration Paul E Simonsen 1*, Yahya
More informationReproductive Aspects of the Mosquito Culex quinquefasciatus (Diptera:Culicidae) Infected with Wuchereria bancrofti (Spirurida: Onchocercidae)
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 98(2): 217-222, March 03 217 Reproductive Aspects of the Mosquito Culex quinquefasciatus (Diptera:Culicidae) Infected with Wuchereria bancrofti (Spirurida: Onchocercidae)
More informationInfluence of Maternal Filariasis on Childhood Infection and Immunity to Wuchereria bancrofti in Kenya
INFECTION AND IMMUNITY, Sept. 2003, p. 5231 5237 Vol. 71, No. 9 0019-9567/03/$08.00 0 DOI: 10.1128/IAI.71.9.5231 5237.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved. Influence
More informationSUMMARY OF THE THIRD MEETING OF THE ITFDE(II) October 18, 2002
SUMMARY OF THE THIRD MEETING OF THE ITFDE(II) October 18, 2002 This meeting of the International Task Force for Disease Eradication (ITFDE) was convened at The Carter Center from 9:00am to 4:00pm on October
More informationEosinophilic lung diseases
Eosinophilic lung diseases Chai Gin Tsen Department of Respiratory and Critical Care Medicine Tan Tock Seng Hospital The eyes do not see what the mind does not know Not very common A high index of suspicion
More informationUSE OF ROUTINELY COLLECTED PAST SURVEILLANCE DATA IN IDENTIFYING AND MAPPING HIGH-RISK AREAS IN A MALARIA ENDEMIC AREA OF SRI LANKA
USE OF ROUTINELY COLLECTED PAST SURVEILLANCE DATA IN IDENTIFYING AND MAPPING HIGH-RISK AREAS IN A MALARIA ENDEMIC AREA OF SRI LANKA AR Wickremasinghe 1, DM Gunawardena 2 and STC Mahawithanage 3 1 Department
More informationin control group 7, , , ,
Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring
More informationLipid profile variations before and after diethyl carbamazine citrate (dec) treatment in filariasis
Original article: Lipid profile variations before and after diethyl carbamazine citrate (dec) treatment in filariasis 1Dr.CH.Ratna Kumar, 2 Dr G.Vijaya Kumar, 3 Dr.R.Suryanarayana Raju, 4 Dr.G.V.Benerji,
More informationLipid profile variations before and after diethyl carbamazine citrate (DEC) treatment in filariasis
Original article: Lipid profile variations before and after diethyl carbamazine citrate (DEC) treatment in filariasis Dr.V.Sai Dilip 1, Dr.G.Chandra Sekhar 1, Dr.Gopala Krishna Murthy 1, Dr.A.S.Kameswara
More informationStitaya Sirisinha, Runglawan Chawengkirttikul.and. Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand.
Stitaya Sirisinha, Runglawan Chawengkirttikul.and Rasana Sennswan Department of Microbiology, Faculty of Science, Mahidol University, Bangkok 10400, Thailand. Abstract. Monoclonal antibody-based enzyme-linked
More informationGiardiasis. Table of Contents
Table of Contents Case Definition... Error! Bookmark not defined. Reporting Requirements... 2 Etiology... Error! Bookmark not defined. Clinical Presentation... Error! Bookmark not defined. Diagnosis...
More informationLeprosy control, elimination & eradication
Leprosy control, elimination & eradication Dr Sunil Deepak Genova, 23 April 28 sunil.deepak@aifo.it Background WHA 1991 resolution to eliminate leprosy as a public health problem. defined elimination as
More informationFaculty and Department: Faculty of Science and Technology, Biomedical Sciences. Status: Option, BSc Biomedical Sciences, Westminster elective module
MODULE PROFORMA Full module title: Human Parasitology Module code: 5BIOM009W Credit level: 5 Length: One semester UK credit value: 20 ECTS value: 10 Faculty and Department: Faculty of Science and Technology,
More informationEliminate Dengue: Our Challenge
March 2013 Eliminate Dengue: Our Challenge Wolbachia pipientis Discovered in 1924 in Culex pipiens ovaries W W m W W Only lives inside host cells Not infectious Only transmitted through the eggs TEM by
More informationManagement And Treatment Of Tropical Diseases By B. G. Maegraith
Management And Treatment Of Tropical Diseases By B. G. Maegraith David Mabey London School of Hygiene and - David Mabey is a physician specialising in Infectious and Tropical Diseases. Mabey, D. ; Peeling,
More informationUse of recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis
~ VOLUML 1 NO. 5 PP 575-580 OCTOBER 1996 Use of recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis R. Chandrashekar', A. F. Ogunrinade' and G. J. Weil' ' Departments
More informationM. Haarbrink, 1 G. K. Abadi, 4 W. A. Buurman, 2 M. A. Dentener, 3 A. J. Terhell, 1 and M. Yazdanbakhsh 1
564 Strong Association of Interleukin-6 and Lipopolysaccharide-Binding Protein with Severity of Adverse Reactions after Diethylcarbamazine Treatment of Microfilaremic Patients M. Haarbrink, 1 G. K. Abadi,
More information1.1.2 Discovery of Microfilariae (1863 and 1866)
CHAPTER-2 1 REVIEW OF LITERATURE Lymphatic filariasis is vector borne parasitic disease caused by three lymphatic dwelling nematode worms living in the lymphatic system, namely Wuchereria bancrofti, Brugia
More informationLymphatic Filariasis: Disease Outbreaks in Military Deployments from World War II
MILITARY MEDICINE, 170, 7:585, 2005 Lymphatic Filariasis: Disease Outbreaks in Military Deployments from World War II Guarantor: LTCOL Peter A. Leggat, RAAMC Contributors: Wayne Melrose, DrPH*; LTCOL Peter
More informationPATIENT INFORMATION LEAFLET
PATIENT INFORMATION LEAFLET Page 1 of 5 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Diethylcarbamazine Citrate Tablets 100 mg USP * (DEC Tablets) diethylcarbamazine citrate DIETHYLCARBAMAZINE
More information